NOVARTIS PHARMA

{
  "facts": [
    {
      "type": "filing",
      "quote": "neergelegd/ontvangen op 07 MEI 2026",
      "value": "2026-05-07",
      "object": null,
      "subject": "novartis_pharma"
    },
    {
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 15/05/2026",
      "value": "2026-05-15",
      "object": null,
      "subject": "novartis_pharma"
    },
    {
      "type": "seat_change",
      "quote": "de zetel van de Vennootschap met ingang van dezelfde datum wordt verplaatst van Medialaan 40, 1800 Vilvoorde naar Kouterveldstraat 2, 1831 Diegem (Machelen)",
      "value": {
        "new_address": "Kouterveldstraat 2, 1831 Diegem (Machelen)",
        "old_address": "Medialaan 40, 1800 Vilvoorde",
        "effective_date": "2026-05-18"
      },
      "object": null,
      "subject": "novartis_pharma"
    },
    {
      "type": "board_meeting",
      "quote": "uittreksels uit de schriftelijke besluiten van de raad van bestuur dd. 29 april 2026",
      "value": "2026-04-29",
      "object": null,
      "subject": "novartis_pharma"
    },
    {
      "type": "power_of_attorney",
      "quote": "BESLUITEN om een bijzondere volmacht te verlenen aan Willem Witters",
      "value": {
        "date": "2026-04-29",
        "purpose": "vervulling van de formaliteiten bij het rechtspersonenregister en, desgevallend, bij de btw-administratie, alsook bij een ondernemingsloket",
        "granted_by": "raad van bestuur"
      },
      "object": "willem_witters",
      "subject": "novartis_pharma"
    },
    {
      "type": "power_of_attorney",
      "quote": "BESLUITEN om een bijzondere volmacht te verlenen aan ... Sayanah Staelens",
      "value": {
        "date": "2026-04-29",
        "purpose": "vervulling van de formaliteiten bij het rechtspersonenregister en, desgevallend, bij de btw-administratie, alsook bij een ondernemingsloket",
        "granted_by": "raad van bestuur"
      },
      "object": "sayanah_staelens",
      "subject": "novartis_pharma"
    },
    {
      "type": "power_of_attorney",
      "quote": "BESLUITEN om een bijzondere volmacht te verlenen aan ... Tibo Serdons",
      "value": {
        "date": "2026-04-29",
        "purpose": "vervulling van de formaliteiten bij het rechtspersonenregister en, desgevallend, bij de btw-administratie, alsook bij een ondernemingsloket",
        "granted_by": "raad van bestuur"
      },
      "object": "tibo_serdons",
      "subject": "novartis_pharma"
    },
    {
      "type": "power_of_attorney",
      "quote": "BESLUITEN om een bijzondere volmacht te verlenen aan ... advocaat of medewerker van het advocatenkantoor Quinz BV",
      "value": {
        "date": "2026-04-29",
        "purpose": "vervulling van de formaliteiten bij het rechtspersonenregister en, desgevallend, bij de btw-administratie, alsook bij een ondernemingsloket",
        "granted_by": "raad van bestuur"
      },
      "object": "quinz_bv",
      "subject": "novartis_pharma"
    },
    {
      "type": "power_of_attorney",
      "quote": "BESLUITEN om een bijzondere volmacht te verlenen aan ... Ad-Ministerie BV",
      "value": {
        "date": "2026-04-29",
        "purpose": "vervulling van de formaliteiten bij het rechtspersonenregister en, desgevallend, bij de btw-administratie, alsook bij een ondernemingsloket",
        "granted_by": "raad van bestuur"
      },
      "object": "ad_ministerie_bv",
      "subject": "novartis_pharma"
    },
    {
      "type": "power_of_attorney",
      "quote": "BESLUITEN om een bijzondere volmacht te verlenen aan ... Ad-Ministerie BV, vertegenwoordigd door Adriaan de Leeuw",
      "value": {
        "date": "2026-04-29",
        "purpose": "vervulling van de formaliteiten bij het rechtspersonenregister en, desgevallend, bij de btw-administratie, alsook bij een ondernemingsloket",
        "granted_by": "raad van bestuur"
      },
      "object": "adriaan_de_leeuw",
      "subject": "novartis_pharma"
    },
    {
      "type": "act_object",
      "quote": "Onderwerp akte: Wljziging Zetel - Volmacht",
      "value": "Wljziging Zetel - Volmacht",
      "object": null,
      "subject": null
    }
  ],
  "act_meta": {
    "model_id": 40,
    "extractor": "open-capture-27b-v3",
    "ocr_chars": 2809,
    "truncated": false,
    "needs_verify": true
  },
  "entities": [
    {
      "id": "novartis_pharma",
      "kbo": "0459.093.476",
      "kind": "company",
      "name": "NOVARTIS PHARMA",
      "attrs": {
        "new_seat": "Kouterveldstraat 2, 1831 Diegem (Machelen)",
        "old_seat": "Medialaan 40 - 1800 Vilvoorde",
        "legal_form": "Naamloze vennootschap"
      }
    },
    {
      "id": "quinz_bv",
      "kbo": "0837.393.773",
      "kind": "org",
      "name": "Quinz BV",
      "attrs": {
        "seat": "Medialaan 28B 1800 Vilvoorde, Belgi\u00EB"
      }
    },
    {
      "id": "ad_ministerie_bv",
      "kbo": "0474.966.438",
      "kind": "org",
      "name": "Ad-Ministerie BV",
      "attrs": {
        "seat": "Brusselsesteenweg 66, 1860 Meise, Belgi\u00EB"
      }
    },
    {
      "id": "willem_witters",
      "kbo": null,
      "kind": "person",
      "name": "Willem Witters",
      "attrs": {}
    },
    {
      "id": "sayanah_staelens",
      "kbo": null,
      "kind": "person",
      "name": "Sayanah Staelens",
      "attrs": {}
    },
    {
      "id": "tibo_serdons",
      "kbo": null,
      "kind": "person",
      "name": "Tibo Serdons",
      "attrs": {}
    },
    {
      "id": "adriaan_de_leeuw",
      "kbo": null,
      "kind": "person",
      "name": "Adriaan de Leeuw",
      "attrs": {}
    }
  ]
}

{
  "facts": [
    {
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 27/04/2026",
      "value": "2026-04-27",
      "object": null,
      "subject": "novartis_pharma"
    },
    {
      "type": "filing",
      "quote": "neergelegd/ontvangen op 20-APR.- 2026",
      "value": "2026-04-20",
      "object": null,
      "subject": "novartis_pharma"
    },
    {
      "type": "act_object",
      "quote": "Onderwerp akte: Wijziging Zetel - Volmacht",
      "value": "Wijziging Zetel - Volmacht",
      "object": null,
      "subject": "novartis_pharma"
    },
    {
      "type": "board_meeting",
      "quote": "uittreksel uit de notulen van de vergadering van de raad van bestuur van 16 april 2026",
      "value": "2026-04-16",
      "object": null,
      "subject": "novartis_pharma"
    },
    {
      "type": "seat_change",
      "quote": "BESLUITEN om met ingang vanaf 18 mei 2026 de zetel van de Vennootschap te verplaatsen van Medialaan 40, 1800 Vilvoorde naar Kouterveldstraat 2 bus 0501, 1831 Diegem (Machelen)",
      "value": {
        "to": "Kouterveldstraat 2 bus 0501, 1831 Diegem (Machelen)",
        "from": "Medialaan 40, 1800 Vilvoorde",
        "effective_date": "2026-05-18"
      },
      "object": null,
      "subject": "novartis_pharma"
    },
    {
      "type": "power_of_attorney",
      "quote": "BESLUITEN om een bijzondere volmacht te verlenen aan Willem Witters",
      "value": "bijzondere volmacht",
      "object": "novartis_pharma",
      "subject": "willem_witters"
    },
    {
      "type": "power_of_attorney",
      "quote": "BESLUITEN om een bijzondere volmacht te verlenen aan ... Sayanah Staelens",
      "value": "bijzondere volmacht",
      "object": "novartis_pharma",
      "subject": "sayanah_staelens"
    },
    {
      "type": "power_of_attorney",
      "quote": "BESLUITEN om een bijzondere volmacht te verlenen aan ... Tibo Serdons",
      "value": "bijzondere volmacht",
      "object": "novartis_pharma",
      "subject": "tibo_serdons"
    },
    {
      "type": "power_of_attorney",
      "quote": "BESLUITEN om een bijzondere volmacht te verlenen aan ... advocaat of medewerker van het advocatenkantoor Quinz BV",
      "value": "bijzondere volmacht",
      "object": "novartis_pharma",
      "subject": "quinz_bv"
    },
    {
      "type": "power_of_attorney",
      "quote": "BESLUITEN om een bijzondere volmacht te verlenen aan ... Ad-Ministerie BV",
      "value": "bijzondere volmacht",
      "object": "novartis_pharma",
      "subject": "ad_ministerie_bv"
    },
    {
      "type": "power_of_attorney",
      "quote": "BESLUITEN om een bijzondere volmacht te verlenen aan ... Ad-Ministerie BV, vertegenwoordigd door Adriaan de Leeuw",
      "value": "bijzondere volmacht",
      "object": "novartis_pharma",
      "subject": "adriaan_de_leeuw"
    }
  ],
  "act_meta": {
    "model_id": 40,
    "extractor": "open-capture-27b-v3",
    "ocr_chars": 2422,
    "truncated": false,
    "needs_verify": true
  },
  "entities": [
    {
      "id": "novartis_pharma",
      "kbo": "0459.093.476",
      "kind": "company",
      "name": "NOVARTIS PHARMA",
      "attrs": {
        "address": "Medialaan 40 - 1800 Vilvoorde",
        "legal_form": "Naamloze vennootschap"
      }
    },
    {
      "id": "willem_witters",
      "kbo": null,
      "kind": "person",
      "name": "Willem Witters",
      "attrs": {
        "role": "volmacht"
      }
    },
    {
      "id": "sayanah_staelens",
      "kbo": null,
      "kind": "person",
      "name": "Sayanah Staelens",
      "attrs": {
        "role": "volmacht"
      }
    },
    {
      "id": "tibo_serdons",
      "kbo": null,
      "kind": "person",
      "name": "Tibo Serdons",
      "attrs": {
        "role": "volmacht"
      }
    },
    {
      "id": "quinz_bv",
      "kbo": "0837.393.773",
      "kind": "org",
      "name": "Quinz BV",
      "attrs": {
        "address": "Medialaan 28B, 1800 Vilvoorde, Belgi\u00EB"
      }
    },
    {
      "id": "ad_ministerie_bv",
      "kbo": "0474.966.438",
      "kind": "org",
      "name": "Ad-Ministerie BV",
      "attrs": {
        "address": "Brusselsesteenweg 66, 1860 Meise"
      }
    },
    {
      "id": "adriaan_de_leeuw",
      "kbo": null,
      "kind": "person",
      "name": "Adriaan de Leeuw",
      "attrs": {
        "role": "vertegenwoordigd door"
      }
    }
  ]
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0459.093.476",
    "name_full": "NOVARTIS PHARMA",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Steven Veyt",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0419122548",
        "name": "KPMG Bedrijfsrevisoren BV",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "Na beraadslaging besluit de algemene vergadering eenparig tot de verlenging van het mandaat van KPMG Bedrijfsrevisoren BV, vertegenwoordigd door de heer Steven Veyt, met maatschappelijke zetel te Luchthaven Brussel Nationaal 1K, 1930 Zaventem, en geregistreerd bij de KBO met ondernemingsnummer (RPR "
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0459.093.476",
    "name_full": "NOVARTIS PHARMA",
    "legal_form": "NV"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0459.093.476",
    "name_full": "NOVARTIS PHARMA",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "capital_decrease",
      "amount": 65000000.0,
      "currency": "EUR",
      "after_eur": 7145000.0,
      "delta_eur": -65000000.0,
      "before_eur": 72145000.0,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2023-06-15",
      "evidence_quote": "De vergadering beslist het kapitaal, overeenkomstig artikel 7:209 van het Wetboek van vennootschappen en verenigingen, te verminderen met een bedrag van vijfenzestig miljoen euro (\u20AC 65.000.000,00), om het te brengen van twee\u00EBnzeventig miljoen honderdvijfenveertigduizend euro (\u20AC 72.145.000,00) op zeven miljoen honderdvijfenveertigduizend euro (\u20AC 7.145.000,00).",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0459.093.476",
    "name_full": "NOVARTIS PHARMA",
    "legal_form": "NV"
  }
}

{
  "facts": [
    {
      "type": "act_object",
      "quote": "Onderwerp akte: Benoeming bestuurders en commissaris - Nieuwe vaste vertegenwoordigers van bestuurders - Benoeming voorzitter",
      "value": "Benoeming bestuurders en commissaris - Nieuwe vaste vertegenwoordigers van bestuurders - Benoeming voorzitter",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2023-05-03",
      "type": "filing",
      "quote": "neergelegd/ontvangen op 03 MEI 2023",
      "value": "03/05/2023",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2023-03-22",
      "type": "general_meeting",
      "quote": "GEWONE ALGEMENE VERGADERING VAN 22 MAART 2023",
      "value": "22/03/2023",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2023-03-22",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 1. AstraZeneca N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2023-03-22"
      },
      "object": "e1",
      "subject": "e2",
      "_value_raw": {
        "role": "bestuurder",
        "start_date": "22/03/2023"
      }
    },
    {
      "date": "2023-03-22",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 2. Bristol-Myers Squibb Belgium N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2023-03-22"
      },
      "object": "e1",
      "subject": "e3",
      "_value_raw": {
        "role": "bestuurder",
        "start_date": "22/03/2023"
      }
    },
    {
      "date": "2023-03-22",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 3.GlaxoSmithKline Pharmaceuticals N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2023-03-22"
      },
      "object": "e1",
      "subject": "e4",
      "_value_raw": {
        "role": "bestuurder",
        "start_date": "22/03/2023"
      }
    },
    {
      "date": "2023-03-22",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 4.Janssen-Cilag N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2023-03-22"
      },
      "object": "e1",
      "subject": "e5",
      "_value_raw": {
        "role": "bestuurder",
        "start_date": "22/03/2023"
      }
    },
    {
      "date": "2023-03-22",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 5.Novartis Pharma N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2023-03-22"
      },
      "object": "e1",
      "subject": "e6",
      "_value_raw": {
        "role": "bestuurder",
        "start_date": "22/03/2023"
      }
    },
    {
      "date": "2023-03-22",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 6.Sanofi Belgium N.V.",
      "value": {
        "role": "bestuurder",
        "start_date": "2023-03-22"
      },
      "object": "e1",
      "subject": "e7",
      "_value_raw": {
        "role": "bestuurder",
        "start_date": "22/03/2023"
      }
    },
    {
      "date": "2023-03-22",
      "type": "auditor_appointment",
      "quote": "De Algemene Vergadering bevestigt de herbenoeming voor een periode van drie jaar van de commissaris KPMG Bedrijfsrevisoren BV",
      "value": {
        "role": "commissaris",
        "term": "drie jaar",
        "start_date": "22/03/2023"
      },
      "object": "e1",
      "subject": "e8"
    },
    {
      "date": "2023-01-01",
      "type": "permanent_representative",
      "quote": "UCB Pharma N.V. ... heeft als nieuwe vaste vertegenwoordiger vanaf 01/01/2023 de heer Xavier Hormaechea",
      "value": {
        "start_date": "01/01/2023"
      },
      "object": "e9",
      "subject": "e10"
    },
    {
      "date": "2023-01-19",
      "type": "permanent_representative",
      "quote": "GlaxoSmithKline Pharmaceuticals N.V. ... heeft als nieuwe vaste vertegenwoordiger vanat 19/01/2023 mevrouw Emmanuelle Boishardy",
      "value": {
        "start_date": "19/01/2023"
      },
      "object": "e4",
      "subject": "e12"
    },
    {
      "date": "2023-04-19",
      "type": "board_meeting",
      "quote": "VERGADERING VAN DE RAAD VAN BESTUUR VAN 19 APRIL 2023",
      "value": "19/04/2023",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2023-04-19",
      "type": "officer_appointment",
      "quote": "Op de Raad van Bestuur van 19 april 2023 werd de heer Fr\u00E9d\u00E9ric Clais tot voorzitter van de Raad van Bestuun benoemd.",
      "value": {
        "role": "voorzitter van de Raad van Bestuur",
        "start_date": "2023-04-19"
      },
      "object": "e1",
      "subject": "e14",
      "_value_raw": {
        "role": "voorzitter van de Raad van Bestuur",
        "start_date": "19/04/2023"
      }
    },
    {
      "type": "permanent_representative",
      "quote": "UCB Pharma N.V. (BE 0403.096.168) heeft als nieuwe vaste vertegenwoordiger vanaf 01/01/2023 de heer Xavier Hormaechea in opvolging van de heer Willy Cnops.",
      "value": {
        "end_date": "01/01/2023"
      },
      "object": "e9",
      "subject": "e11"
    },
    {
      "type": "permanent_representative",
      "quote": "GlaxoSmithKline Pharmaceuticals N.V. (BE 0403.066.474) heeft als nieuwe vaste vertegenwoordiger vanat 19/01/2023 mevrouw Emmanuelle Boishardy, in opvolging van mevrouw Sabena Solomon.",
      "value": {
        "end_date": "19/01/2023"
      },
      "object": "e4",
      "subject": "e13"
    }
  ],
  "act_meta": {
    "outcome": "corrected",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 2632,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "company",
      "name": "Algemene Vereniging van de Geneesmiddelenindustrie",
      "attrs": {
        "seat": "Terhulpsesteenweg 166, 1170 Brussel",
        "legal_form": "Vereniging zonder Winstoogmerk",
        "short_name": "AVGI"
      }
    },
    {
      "id": "e2",
      "kbo": "0400.165.679",
      "kind": "company",
      "name": "AstraZeneca N.V.",
      "attrs": {
        "seat": "Alfons Gossetlaan 40 bus 201, 1702 Groot-Bijgaarden"
      }
    },
    {
      "id": "e3",
      "kbo": "0403.075.184",
      "kind": "company",
      "name": "Bristol-Myers Squibb Belgium N.V.",
      "attrs": {
        "seat": "avenue de Finlande 4 Bte 48, 1420 Braine-L\u0027Alleud"
      }
    },
    {
      "id": "e4",
      "kbo": "0403.066.474",
      "kind": "company",
      "name": "GlaxoSmithKline Pharmaceuticals N.V.",
      "attrs": {
        "seat": "avenue Pascal 2-4-6, 1300 Wavre"
      }
    },
    {
      "id": "e5",
      "kbo": "0415.283.427",
      "kind": "company",
      "name": "Janssen-Cilag N.V.",
      "attrs": {
        "seat": "Antwerpseweg 15-17, 2340 Beerse"
      }
    },
    {
      "id": "e6",
      "kbo": "0459.093.476",
      "kind": "company",
      "name": "Novartis Pharma N.V.",
      "attrs": {
        "seat": "Medialaan 40 bus 1, 1800 Vilvoorde"
      }
    },
    {
      "id": "e7",
      "kbo": "0464.435.901",
      "kind": "company",
      "name": "Sanofi Belgium N.V.",
      "attrs": {
        "seat": "Leonardo Da Vincilaan 19, 1831 Diegem"
      }
    },
    {
      "id": "e8",
      "kbo": "0419.122.548",
      "kind": "company",
      "name": "KPMG Bedrijfsrevisoren BV",
      "attrs": {
        "seat": "Bourgetlaan 40, 1130 Brussel"
      }
    },
    {
      "id": "e9",
      "kbo": "0403.096.168",
      "kind": "company",
      "name": "UCB Pharma N.V.",
      "attrs": {}
    },
    {
      "id": "e10",
      "kbo": null,
      "kind": "person",
      "name": "Xavier Hormaechea",
      "attrs": {}
    },
    {
      "id": "e11",
      "kbo": null,
      "kind": "person",
      "name": "Willy Cnops",
      "attrs": {}
    },
    {
      "id": "e12",
      "kbo": null,
      "kind": "person",
      "name": "Emmanuelle Boishardy",
      "attrs": {}
    },
    {
      "id": "e13",
      "kbo": null,
      "kind": "person",
      "name": "Sabena Solomon",
      "attrs": {}
    },
    {
      "id": "e14",
      "kbo": null,
      "kind": "person",
      "name": "Fr\u00E9d\u00E9ric Clais",
      "attrs": {}
    },
    {
      "id": "e15",
      "kbo": null,
      "kind": "person",
      "name": "Caroline Ven",
      "attrs": {}
    }
  ]
}

{
  "facts": [
    {
      "type": "act_object",
      "quote": "Objet de l\u0027acte : Nouveaux administrateurs et commissaire - nouveaux repr\u00E9sentants permanents des administrateurs - Nomination pr\u00E9sident",
      "value": "Nouveaux administrateurs et commissaire - nouveaux repr\u00E9sentants permanents des administrateurs - Nomination pr\u00E9sident",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2023-05-03",
      "type": "filing",
      "quote": "neergelegd/ontvangen op 03 MEI 2023",
      "value": "03/05/2023",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2023-03-22",
      "type": "general_meeting",
      "quote": "ASSEMBLEE GENERALE ORDINAIRE DU 22 MARS 2023",
      "value": "22/03/2023",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 1.AstraZeneca S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e2",
      "_value_raw": {
        "role": "administrateur",
        "term": null,
        "start_date": null
      }
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 2.Bristol-Myers Squibb Belgium S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e3",
      "_value_raw": {
        "role": "administrateur",
        "term": null,
        "start_date": null
      }
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 3.GlaxoSmithKline Pharmaceuticals S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e4",
      "_value_raw": {
        "role": "administrateur",
        "term": null,
        "start_date": null
      }
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 4.Janssen-Cilag S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e5",
      "_value_raw": {
        "role": "administrateur",
        "term": null,
        "start_date": null
      }
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 5.Novartis Pharma S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e6",
      "_value_raw": {
        "role": "administrateur",
        "term": null,
        "start_date": null
      }
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 5.Sanofi Belgium S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": "e1",
      "subject": "e7",
      "_value_raw": {
        "role": "administrateur",
        "term": null,
        "start_date": null
      }
    },
    {
      "type": "auditor_appointment",
      "quote": "L\u0027Assembl\u00E9e g\u00E9n\u00E9rale confirme la reconduction de la nomination pour une p\u00E9riode de trois ans du commissaire KPMG R\u00E9viseurs d\u0027Entreprises SRL",
      "value": {
        "role": "commissaire",
        "term": "trois ans",
        "start_date": null
      },
      "object": "e1",
      "subject": "e8"
    },
    {
      "date": "2023-01-01",
      "type": "permanent_representative",
      "quote": "UCB Pharma N.V. ... a d\u00E9sign\u00E9 comme nouveau repr\u00E9sentant permanent \u00E0 partir du 01/01/2023 Monsieur Xavier Hormaechea",
      "value": {
        "start_date": "01/01/2023"
      },
      "object": "e9",
      "subject": "e10"
    },
    {
      "date": "2023-01-19",
      "type": "permanent_representative",
      "quote": "GlaxoSmithKline Pharmaceuticals N.V. ... a d\u00E9sign\u00E9 comme nouveau repr\u00E9sentant permanent \u00E0 partir du 19/01/2023 Madame Emmanuelle Boishardy",
      "value": {
        "start_date": "19/01/2023"
      },
      "object": "e12",
      "subject": "e13"
    },
    {
      "date": "2023-04-19",
      "type": "board_meeting",
      "quote": "REUNION DU CONSEIL D\u0027ADMINISTRATION DU 19 AVRIL 2023",
      "value": "19/04/2023",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "officer_appointment",
      "quote": "Lors du Conseil d\u0027administration du 19 avril 2023, Monsieur Fr\u00E9d\u00E9ric Clais a \u00E9t\u00E9 d\u00E9sign\u00E9 comme Pr\u00E9sident du Conseil d\u0027administration.",
      "value": {
        "role": "Pr\u00E9sident du Conseil d\u0027administration"
      },
      "object": "e1",
      "subject": "e15",
      "_value_raw": {
        "role": "Pr\u00E9sident du Conseil d\u0027administration",
        "term": null,
        "start_date": null
      }
    }
  ],
  "act_meta": {
    "outcome": "clean",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 2645,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "company",
      "name": "Association G\u00E9n\u00E9rale de l\u0027Industrie du M\u00E9dicament",
      "attrs": {
        "seat": "chauss\u00E9e de La Hulpe 166, 1170 Bruxelles",
        "legal_form": "Association sans But Lucratif",
        "short_name": "AGIM"
      }
    },
    {
      "id": "e2",
      "kbo": "0400.165.679",
      "kind": "company",
      "name": "AstraZeneca S.A.",
      "attrs": {
        "seat": "Alfons Gossetlaan 40 bte 201, 1702 Groot-Bijgaarden"
      }
    },
    {
      "id": "e3",
      "kbo": "0403.075.184",
      "kind": "company",
      "name": "Bristol-Myers Squibb Belgium S.A.",
      "attrs": {
        "seat": "avenue de Finlande 4 Bte 48, 1420 Braine-L\u0027Alleud"
      }
    },
    {
      "id": "e4",
      "kbo": "0403.066.474",
      "kind": "company",
      "name": "GlaxoSmithKline Pharmaceuticals S.A.",
      "attrs": {
        "seat": "avenue Pascal 2-4-6, 1300 Wavre"
      }
    },
    {
      "id": "e5",
      "kbo": "0415.283.427",
      "kind": "company",
      "name": "Janssen-Cilag S.A.",
      "attrs": {
        "seat": "Antwerpseweg 15-17, 2340 Beerse"
      }
    },
    {
      "id": "e6",
      "kbo": "0459.093.476",
      "kind": "company",
      "name": "Novartis Pharma S.A.",
      "attrs": {
        "seat": "Medialaan 40, bte 1, 1800 Vilvoorde"
      }
    },
    {
      "id": "e7",
      "kbo": "0464.435.901",
      "kind": "company",
      "name": "Sanofi Belgium S.A.",
      "attrs": {
        "seat": "Leonardo Da Vincilaan 19, 1831 Diegem"
      }
    },
    {
      "id": "e8",
      "kbo": "0419.122.548",
      "kind": "company",
      "name": "KPMG R\u00E9viseurs d\u0027Entreprises SRL",
      "attrs": {
        "seat": "avenue du Bourget 40, 1130 Bruxelles"
      }
    },
    {
      "id": "e9",
      "kbo": "0403.096.168",
      "kind": "company",
      "name": "UCB Pharma N.V.",
      "attrs": {}
    },
    {
      "id": "e10",
      "kbo": null,
      "kind": "person",
      "name": "Xavier Hormaechea",
      "attrs": {}
    },
    {
      "id": "e11",
      "kbo": null,
      "kind": "person",
      "name": "Willy Cnops",
      "attrs": {}
    },
    {
      "id": "e12",
      "kbo": "0403.066.474",
      "kind": "company",
      "name": "GlaxoSmithKline Pharmaceuticals N.V.",
      "attrs": {}
    },
    {
      "id": "e13",
      "kbo": null,
      "kind": "person",
      "name": "Emmanuelle Boishardy",
      "attrs": {}
    },
    {
      "id": "e14",
      "kbo": null,
      "kind": "person",
      "name": "Sabena Solomon",
      "attrs": {}
    },
    {
      "id": "e15",
      "kbo": null,
      "kind": "person",
      "name": "Fr\u00E9d\u00E9ric Clais",
      "attrs": {}
    }
  ]
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 65000000.0,
      "currency": "EUR",
      "after_eur": 72145000.0,
      "delta_eur": 65000000.0,
      "before_eur": 7145000.0,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2022-12-19",
      "evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen door inbreng in geld met een bedrag van vijfenzestig miljoen euro (\u20AC 65.000.000,00), om het van zeven miljoen honderdvijfenveertigduizend euro (\u20AC 7.145.000,00) te brengen op twee\u00EBnzeventig miljoen honderdvijfenveertigduizend euro (\u20AC 72.145.000,00)",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0459.093.476",
    "name_full": "NOVARTIS PHARMA",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Nicola Bencini",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2022-07-01",
      "evidence_quote": "De aandeelhouders nemen kennis van het ontslag van (en ontslaan hem om elke twijfel uit te sluiten) de heer Nicola Bencini als bestuurder van de Vennootschap met ingang vanaf 1 juli 2022.",
      "discharge_granted": false
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Nicolas Istas",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2022-07-01",
      "evidence_quote": "De aandeelhouders benoemen de heer Nicolas Istas, te dien eind met woonstkeuze op de zetel van de Vennootschap, die aanvaardt, als bestuurder van de Vennootschap vanaf 1 juli 2022 en voor een termijn van zes jaar."
    },
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Steven Veyt",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0419122548",
        "name": "KPMG Bedrijfsrevisoren BV",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "Na beraadslaging besluit de algemene vergadering eenparig tct benoeming van KPMG Bedrijfsrevisoren BV, vertegenwoordigd door de heer Steven Veyt, met maatschappelijke zetel te Luchthaven Brussel Nationaal 1K, 1930 Zaventem, en geregistreerd bij de KBO met ondenemingsnummer (RPR Brussel) 0419.122.548"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0459.093.476",
    "name_full": "NOVARTIS PHARMA",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Guy Oliver",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2022-03-01",
      "evidence_quote": "De aandeelhouders nemen kennis van het ontslag van (en ontslaan hen om elke twijfel uit te sluiten) de heer Guy Oliver en de heer Nicolas Thiriet als bestuurders van de Vennootschap met ingang vanaf 1 maart 2022.",
      "discharge_granted": false
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Nicolas Thiriet",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2022-03-01",
      "evidence_quote": "De aandeelhouders nemen kennis van het ontslag van (en ontslaan hen om elke twijfel uit te sluiten) de heer Guy Oliver en de heer Nicolas Thiriet als bestuurders van de Vennootschap met ingang vanaf 1 maart 2022.",
      "discharge_granted": false
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Nicola Bencini",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2022-03-01",
      "evidence_quote": "De aandeelhouders benoemen: -De heer Nicola Bencini, met de Italiaanse nationaliteit en met geboortedatum 29 november 1977; en ... te dien eind met woonstkeuze op de zetel van de Vennootschap, die aanvaarden, als bestuurders van de Vennootschap vanaf 1 maart 2022 en voor een termijn van 6 jaar."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Andrea Majocchi",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2022-03-01",
      "evidence_quote": "De aandeelhouders benoemen: ... -De heer Andrea Majocchi met de Italiaanse nationaliteit en met geboortedatum 10 juni 1974; ... te dien eind met woonstkeuze op de zetel van de Vennootschap, die aanvaarden, als bestuurders van de Vennootschap vanaf 1 maart 2022 en voor een termijn van 6 jaar."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0459.093.476",
    "name_full": "NOVARTIS PHARMA",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Federico Mambretti",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-09-21",
      "evidence_quote": "De aandeelhouders benoemen de heren - Federico Mambretti, met de Italiaanse nationaliteit, met geboortedatum 21 juni 1981; en - Guy Oliver, met de Britse nationaliteit, met geboortedatum 4 mei 1978, te dien eind met woonstkeuze op de zetel van de vennootschap, die aanvaarden als bestuurders van de v"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Guy Oliver",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-09-21",
      "evidence_quote": "De aandeelhouders benoemen de heren - Federico Mambretti, met de Italiaanse nationaliteit, met geboortedatum 21 juni 1981; en - Guy Oliver, met de Britse nationaliteit, met geboortedatum 4 mei 1978, te dien eind met woonstkeuze op de zetel van de vennootschap, die aanvaarden als bestuurders van de v"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0459.093.476",
    "name_full": "NOVARTIS PHARMA",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Nicolas Istas",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-06-10",
      "evidence_quote": "De aandeelhouders benoemen de heer Nicolas Istas, met de Belgische nationaliteit, met geboortedatum 31 oktober 1969, te dien eind met woonstkeuze op de zetel van de vennootschap, die aanvaardt, als bestuurder van de vennootschap dit met onmiddellijke ingang en voor een termijn van 6 jaar."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0459.093.476",
    "name_full": "NOVARTIS PHARMA",
    "legal_form": "NV"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0459.093.476",
    "name_full": "NOVARTIS PHARMA",
    "legal_form": "NV"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": true,
    "effective_date": "2021-01-28",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0459.093.476",
    "name_full": "NOVARTIS PHARMA",
    "legal_form": "SA"
  },
  "signature_regime": null,
  "special_mandates": [
    {
      "quote": "De vergadering verleent bijzondere volmacht aan Lannoy Joris, De Dier Stijn en elke andere advocaat of medewerker van het kantoor Quinz, allen woonstkeuze gedaan hebbende te 1800 Vilvoorde, Medialaan 28 B, allen individueel bevoegd, evenals aan hun bedienden, aangestelden en lasthebbers, met mogelijkheid tot indeplaatsstelling, teneinde de vervulling van de formaliteiten bij een ondernemingsloket met het oog op de inschrijving/aanpassing van de gegevens in de Kruispuntbank van Ondernemingen, en, desgevallend, bij de Administratie van de Belasting over de Toegevoegde Waarde, te verzekeren.",
      "holder_kbo": null,
      "holder_name": "Quinz",
      "scope_categories": [
        "KBO",
        "tax",
        "filing"
      ],
      "with_substitution": true
    }
  ],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "facts": [
    {
      "type": "act_object",
      "quote": "Onderwerp akte: Delegatiereglement dagelijks bestuur - Benoeming Voorzitter-Ondervoorzitter Raad van Bestuur - Ontslag algemeen directeur en aanstelling algemeen directeur ad interim - Gewijzigde statuten - Wijzigingen Raad van bestuur",
      "value": "Delegatiereglement dagelijks bestuur - Benoeming Voorzitter-Ondervoorzitter Raad van Bestuur - Ontslag algemeen directeur en aanstelling algemeen directeur ad interim - Gewijzigde statuten - Wijzigingen Raad van bestuur",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2020-07-22",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 22/07/2020",
      "value": "2020-07-22",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2020-07-13",
      "type": "filing",
      "quote": "neergelegd/ontvangen op 13 JULI 2020",
      "value": "2020-07-13",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2020-02-19",
      "type": "board_meeting",
      "quote": "VERGADERING VAN DE RAAD VAN BESTUUR VAN 19 FEBRUARI 2020",
      "value": "2020-02-19",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2020-06-24",
      "type": "board_meeting",
      "quote": "VERGADERING VAN DE RAAD VAN BESTUUR VAN 24 JUNI 2020",
      "value": "2020-06-24",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2020-05-13",
      "type": "general_meeting",
      "quote": "ALGEMENE VERGADERING VAN 13 MEI 2020",
      "value": "2020-05-13",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "officer_resignation",
      "quote": "De raad van bestuur neemt akte van het ontslag van mevrouw Catherine Auguste J. Rutteri ... als algemeen directeur van de vereniging. Dit ontslag zal in werking treden op 1 juli 2020.",
      "value": {
        "role": "algemeen directeur",
        "end_date": "2020-07-01"
      },
      "object": "e1",
      "subject": "e2"
    },
    {
      "date": "2020-07-01",
      "type": "officer_appointment",
      "quote": "Met ingang vanaf 1 juli 2020 wordt mevrouw Ann Maria Marcel Ludo Adriaenseri ... aargesteld als algemeen directeur ad interim van de vereniging.",
      "value": {
        "role": "algemeen directeur ad interim",
        "start_date": "2020-07-01"
      },
      "object": "e1",
      "subject": "e3"
    },
    {
      "type": "officer_appointment",
      "quote": "Op de Raad van Bestuur van 24 juni 2020 werd Pfizer ... verkozen tot nieuwe voorzitter van de Raad van Bestuur",
      "value": {
        "role": "Voorzitter Raad van Bestuur"
      },
      "object": "e1",
      "subject": "e4"
    },
    {
      "type": "permanent_representative",
      "quote": "met als vaste vertegenwoordiger Karel Van De Sompel",
      "value": null,
      "object": "e4",
      "subject": "e5"
    },
    {
      "type": "officer_appointment",
      "quote": "werd Eli Lilly Benelux ... verkozen tot nieuwe ondervoorzitter van de Raad van Bestuur",
      "value": {
        "role": "Ondervoorzitter Raad van Bestuur"
      },
      "object": "e1",
      "subject": "e6"
    },
    {
      "type": "permanent_representative",
      "quote": "met als vaste vertegenwoordiger Fr\u00E9d\u00E9ric Clais",
      "value": null,
      "object": "e6",
      "subject": "e7"
    },
    {
      "type": "officer_appointment",
      "quote": "Benoeming van: 1. AstraZeneca N.V.",
      "value": {
        "role": "bestuurder"
      },
      "object": "e1",
      "subject": "e8"
    },
    {
      "type": "permanent_representative",
      "quote": "met als vaste vertegenwoordiger mevrouw Anne-Laure Dreno",
      "value": null,
      "object": "e8",
      "subject": "e9"
    },
    {
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 1. Bristol-Myers Squibb Belgium N.V.",
      "value": {
        "role": "bestuurder"
      },
      "object": "e1",
      "subject": "e10"
    },
    {
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 2. GlaxoSmithKline Pharmaceuticals N.V.",
      "value": {
        "role": "bestuurder"
      },
      "object": "e1",
      "subject": "e11"
    },
    {
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 3. Janssen-Cilag N.V.",
      "value": {
        "role": "bestuurder"
      },
      "object": "e1",
      "subject": "e12"
    },
    {
      "type": "permanent_representative",
      "quote": "met als nieuwe vaste vertegenwoordiger mevrouw Sonja Willems",
      "value": null,
      "object": "e12",
      "subject": "e13"
    },
    {
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 4. Novartis Pharma N.V.",
      "value": {
        "role": "bestuurder"
      },
      "object": "e1",
      "subject": "e14"
    },
    {
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 5. Sanofi Belgium N.V.",
      "value": {
        "role": "bestuurder"
      },
      "object": "e1",
      "subject": "e15"
    },
    {
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 6. Merck N.V.",
      "value": {
        "role": "bestuurder"
      },
      "object": "e1",
      "subject": "e16"
    },
    {
      "type": "officer_resignation",
      "quote": "Ontslag van: 1. Celgene BVBA",
      "value": {
        "role": "bestuurder"
      },
      "object": "e1",
      "subject": "e17"
    },
    {
      "type": "statute_amendment",
      "quote": "De voorgestelde wijzigingen aan de statuten werden goedgekeurd door de Algemene Vergadering van 13 mei 2020.",
      "value": null,
      "object": null,
      "subject": "e1"
    },
    {
      "type": "purpose",
      "quote": "artikel 3. Belangeloos doel - voorwerp ... Het doel van de Vereniging bestaat in de vertegenwoordiging en de verdediging van de morele en stoffelijke belangen van de geneesmiddelenindustrie in het algemeen en van de innovatieve industrie in het bijzonder.",
      "value": "Het doel van de Vereniging bestaat in de vertegenwoordiging en de verdediging van de morele en stoffelijke belangen van de geneesmiddelenindustrie in het algemeen en van de innovatieve industrie in het bijzonder.",
      "object": null,
      "subject": "e1"
    }
  ],
  "act_meta": {
    "outcome": "corrected",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 83064,
    "truncated": true
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "company",
      "name": "Algemene Vereniging van de Geneesmiddelenindustrie",
      "attrs": {
        "seat": "Terhulpsesteenweg 166, 1170 Brussel",
        "legal_form": "Vereniging zonder Winstoogmerk",
        "short_name": "AVGI"
      }
    },
    {
      "id": "e2",
      "kbo": null,
      "kind": "person",
      "name": "Catherine Auguste J. Rutten",
      "attrs": {
        "address": "Emile Van Becelaerelaan 107, 1170 Watermaal-Bosvoorde",
        "birth_date": "1969-01-28",
        "birth_place": "Leuven"
      }
    },
    {
      "id": "e3",
      "kbo": null,
      "kind": "person",
      "name": "Ann Maria Marcel Ludo Adriaensen",
      "attrs": {
        "address": "Mimosalaan 30, 3191 Hever",
        "birth_date": "1969-07-21",
        "birth_place": "Turnhout"
      }
    },
    {
      "id": "e4",
      "kbo": null,
      "kind": "company",
      "name": "Pfizer",
      "attrs": {}
    },
    {
      "id": "e5",
      "kbo": null,
      "kind": "person",
      "name": "Karel Van De Sompel",
      "attrs": {}
    },
    {
      "id": "e6",
      "kbo": null,
      "kind": "company",
      "name": "Eli Lilly Benelux",
      "attrs": {}
    },
    {
      "id": "e7",
      "kbo": null,
      "kind": "person",
      "name": "Fr\u00E9d\u00E9ric Clais",
      "attrs": {}
    },
    {
      "id": "e8",
      "kbo": "0400.165.679",
      "kind": "company",
      "name": "AstraZeneca N.V.",
      "attrs": {
        "seat": "Alfons Gossetlaan 40 bus 201, 1702 Groot-Bijgaarden"
      }
    },
    {
      "id": "e9",
      "kbo": null,
      "kind": "person",
      "name": "Anne-Laure Dreno",
      "attrs": {
        "address": "avenue du general de Longueville 43, 1150 Brussel",
        "birth_date": "1972-06-18",
        "birth_place": "Parijs (Frankrijk)"
      }
    },
    {
      "id": "e10",
      "kbo": "0403.075.184",
      "kind": "company",
      "name": "Bristol-Myers Squibb Belgium N.V.",
      "attrs": {
        "seat": "avenue de Finlande 4 Bte 48, 1420 Braine-L\u0027Alleud"
      }
    },
    {
      "id": "e11",
      "kbo": "0403.066.474",
      "kind": "company",
      "name": "GlaxoSmithKline Pharmaceuticals N.V.",
      "attrs": {
        "seat": "avenue Pascal 2-4-6, 1300 Wavre"
      }
    },
    {
      "id": "e12",
      "kbo": "0415.283.427",
      "kind": "company",
      "name": "Janssen-Cilag N.V.",
      "attrs": {
        "seat": "Antwerpseweg 15-17, 2340 Beerse"
      }
    },
    {
      "id": "e13",
      "kbo": null,
      "kind": "person",
      "name": "Sonja Willems",
      "attrs": {
        "address": "Kruisstraat 14, 3545 Halen",
        "birth_date": "1960-09-22",
        "birth_place": "Lier"
      }
    },
    {
      "id": "e14",
      "kbo": "0459.093.476",
      "kind": "company",
      "name": "Novartis Pharma N.V.",
      "attrs": {
        "seat": "Medialaan 40 bus 1, 1800 Vilvoorde"
      }
    },
    {
      "id": "e15",
      "kbo": "0464.435.901",
      "kind": "company",
      "name": "Sanofi Belgium N.V.",
      "attrs": {
        "seat": "Leonardo Da Vincilaan 19, 1831 Diegem"
      }
    },
    {
      "id": "e16",
      "kbo": "0403.047.965",
      "kind": "company",
      "name": "Merck N.V.",
      "attrs": {
        "seat": "Brusselsesteenweg 288, 3090 Overijse"
      }
    },
    {
      "id": "e17",
      "kbo": "0882.012.387",
      "kind": "company",
      "name": "Celgene BVBA",
      "attrs": {
        "seat": "Place du Luxembourg 1, 1420 Braine-L\u0027Alleud"
      }
    }
  ]
}

{
  "facts": [
    {
      "type": "act_object",
      "quote": "Objet de l\u0027acte: Nomination Vice-Pr\u00E9sident Conseil d\u0027administration et d\u00E9signation repr\u00E9sentants permanents des administrateurs",
      "value": "Nomination Vice-Pr\u00E9sident Conseil d\u0027administration et d\u00E9signation repr\u00E9sentants permanents des administrateurs",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2020-07-22",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 22/07/2020 - Annexes du Moniteur belge",
      "value": "22/07/2020",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2020-07-13",
      "type": "filing",
      "quote": "neergelegd/ontvangen o 713 JULI 2020",
      "value": "13/07/2020",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2020-02-19",
      "type": "board_meeting",
      "quote": "REUNION DU CONSEIL D\u0027ADMINISTRATION DU 19 FEVRIER 2020",
      "value": "19/02/2020",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "officer_resignation",
      "quote": "Le Conseil d\u0027administration prend acte de la d\u00E9mission de madame Catherine Auguste J. Rutten ... en tant que directeur g\u00E9n\u00E9ral de l\u0027association. Cette d\u00E9mission entrera en vigueur le 1 juillet 2020.",
      "value": {
        "role": "Directeur g\u00E9n\u00E9ral",
        "end_date": "2020-07-01"
      },
      "object": null,
      "subject": "e2"
    },
    {
      "date": "2020-07-01",
      "type": "officer_appointment",
      "quote": "A partir du 1 juillet 2020, madame Ann Maria Marcel Ludo Adriaensen ... a \u00E9t\u00E9 nomm\u00E9e directeur g\u00E9n\u00E9ral ad interim.",
      "value": {
        "role": "Directeur g\u00E9n\u00E9ral ad interim",
        "start_date": "2020-07-01"
      },
      "object": null,
      "subject": "e3"
    },
    {
      "date": "2020-06-24",
      "type": "board_meeting",
      "quote": "REUNION DU CONSEIL D\u0027ADMINISTRATION DU 24 JUIN 2020",
      "value": "24/06/2020",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "officer_appointment",
      "quote": "Lors du Conseil d\u0027administration du 24 juin 2020, Pfizer ... a \u00E9t\u00E9 \u00E9lue nouveau Pr\u00E9sident du Conseil d\u0027administration",
      "value": {
        "role": "Pr\u00E9sident du Conseil d\u0027administration"
      },
      "object": null,
      "subject": "e4"
    },
    {
      "type": "permanent_representative",
      "quote": "Pfizer, avec en tant que repr\u00E9sentant permanent Karel Van De Sompel",
      "value": null,
      "object": "e4",
      "subject": "e5"
    },
    {
      "type": "officer_appointment",
      "quote": "Lors du Conseil d\u0027administration du 24 juin 2020 ... Eli Lilly Benelux ... a \u00E9t\u00E9 \u00E9lue nouveau Vice-Pr\u00E9sident du Conseil d\u0027administration.",
      "value": {
        "role": "Vice-Pr\u00E9sident du Conseil d\u0027administration"
      },
      "object": null,
      "subject": "e6"
    },
    {
      "type": "permanent_representative",
      "quote": "Eli Lilly Benelux, avec en tant que repr\u00E9sentant permanent Fr\u00E9d\u00E9ric Clais",
      "value": null,
      "object": "e6",
      "subject": "e7"
    },
    {
      "date": "2020-05-13",
      "type": "general_meeting",
      "quote": "ASSEMBLEE GENERALE EXTRAORDINAIRE DU 13 MAI 2020",
      "value": "13/05/2020",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "officer_appointment",
      "quote": "Nomination de : 1. AstraZeneca S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": null,
      "subject": "e8"
    },
    {
      "type": "permanent_representative",
      "quote": "AstraZeneca S.A. ... avec en tant que repr\u00E9sentant permanent madame Anne-Laure Dreno",
      "value": null,
      "object": "e8",
      "subject": "e9"
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de : 1. Bristol-Myers Squibb Belgium S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": null,
      "subject": "e10"
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de : ... 2. GlaxoSmithKline Pharmaceuticals S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": null,
      "subject": "e11"
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de : ... 3. Janssen-Cilag S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": null,
      "subject": "e12"
    },
    {
      "type": "permanent_representative",
      "quote": "Janssen-Cilag S.A. ... avec en tant que nouveau repr\u00E9sentant permanent madame Sonja Willems",
      "value": null,
      "object": "e12",
      "subject": "e13"
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de : ... 4. Novartis Pharma S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": null,
      "subject": "e14"
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de : ... 5. Sanofi Belgium S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": null,
      "subject": "e15"
    },
    {
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de : ... 6. Merck S.A.",
      "value": {
        "role": "administrateur"
      },
      "object": null,
      "subject": "e16"
    },
    {
      "type": "officer_resignation",
      "quote": "D\u00E9mission de: 1. Celgene SPRL",
      "value": {
        "role": "administrateur"
      },
      "object": null,
      "subject": "e17"
    },
    {
      "type": "statute_amendment",
      "quote": "Les modifications propos\u00E9es aux statuts ont \u00E9t\u00E9 approuv\u00E9es par l\u0027Assembl\u00E9e G\u00E9n\u00E9rale Extraordinaire du 13 mai 2020. Les statuts modifi\u00E9s sont libell\u00E9s comme suit:",
      "value": null,
      "object": null,
      "subject": "e1"
    },
    {
      "type": "purpose",
      "quote": "article 3. But d\u00E9sint\u00E9ress\u00E9 - Objet Le but poursuivi par l\u0027Association consiste en la repr\u00E9sentation et la d\u00E9fense des int\u00E9r\u00EAts moraux et mat\u00E9riels de l\u0027industrie du m\u00E9dicament en g\u00E9n\u00E9ral et de l\u0027industrie des m\u00E9dicaments innovants en particulier.",
      "value": "Le but poursuivi par l\u0027Association consiste en la repr\u00E9sentation et la d\u00E9fense des int\u00E9r\u00EAts moraux et mat\u00E9riels de l\u0027industrie du m\u00E9dicament en g\u00E9n\u00E9ral et de l\u0027industrie des m\u00E9dicaments innovants en particulier. Parmi les activit\u00E9s concr\u00E8tes men\u00E9es par l\u0027Association en vue de la r\u00E9alisation de son but, on trouve notamment: a)un soutien scientifique, administratif, juridique et organisationnel aux membres... b)l\u0027organisation de toutes activit\u00E9s visant \u00E0 favoriser une meilleure compr\u00E9hension des probl\u00E8mes... c)la promotion... d\u0027une efficiente collaboration entre les membres; d)le d\u00E9veloppement de toutes activit\u00E9s... contribuant directement ou indirectement \u00E0 la r\u00E9alisation du but d\u00E9sint\u00E9ress\u00E9 susmentionn\u00E9...",
      "object": null,
      "subject": "e1"
    }
  ],
  "act_meta": {
    "outcome": "corrected",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 82578,
    "truncated": true
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "company",
      "name": "Association G\u00E9n\u00E9rale de l\u0027Industrie du M\u00E9dicament",
      "attrs": {
        "legal_form": "Association sans But Lucratif",
        "short_name": "AGIM"
      }
    },
    {
      "id": "e2",
      "kbo": null,
      "kind": "person",
      "name": "Catherine Auguste J. Rutten",
      "attrs": {
        "address": "avenue Emile Van Becelaere 107, 1170 Watermael-Boitsfort",
        "birth_date": "1969-01-28",
        "birth_place": "Leuven"
      }
    },
    {
      "id": "e3",
      "kbo": null,
      "kind": "person",
      "name": "Ann Maria Marcel Ludo Adriaensen",
      "attrs": {
        "address": "Mimosalaan 30, 3191 Hever",
        "birth_date": "1969-07-21",
        "birth_place": "Turnhout"
      }
    },
    {
      "id": "e4",
      "kbo": null,
      "kind": "company",
      "name": "Pfizer",
      "attrs": {}
    },
    {
      "id": "e5",
      "kbo": null,
      "kind": "person",
      "name": "Karel Van De Sompel",
      "attrs": {}
    },
    {
      "id": "e6",
      "kbo": null,
      "kind": "company",
      "name": "Eli Lilly Benelux",
      "attrs": {}
    },
    {
      "id": "e7",
      "kbo": null,
      "kind": "person",
      "name": "Fr\u00E9d\u00E9ric Clais",
      "attrs": {}
    },
    {
      "id": "e8",
      "kbo": "0400.165.679",
      "kind": "company",
      "name": "AstraZeneca S.A.",
      "attrs": {
        "seat": "Alfons Gossetlaan 40 bte 201, 1702 Groot-Bijgaarden"
      }
    },
    {
      "id": "e9",
      "kbo": null,
      "kind": "person",
      "name": "Anne-Laure Dreno",
      "attrs": {
        "address": "avenue du general de Longueville 43, 1150 Bruxelles",
        "birth_date": "1972-06-18",
        "birth_place": "Paris (France)"
      }
    },
    {
      "id": "e10",
      "kbo": "0403.075.184",
      "kind": "company",
      "name": "Bristol-Myers Squibb Belgium S.A.",
      "attrs": {
        "seat": "avenue de Finlande 4 Bte 48, 1420 Braine-L\u0027Alleud"
      }
    },
    {
      "id": "e11",
      "kbo": "0403.066.474",
      "kind": "company",
      "name": "GlaxoSmithKline Pharmaceuticals S.A.",
      "attrs": {
        "seat": "avenue Pascal 2-4-6, 1300 Wavre"
      }
    },
    {
      "id": "e12",
      "kbo": "0415.283.427",
      "kind": "company",
      "name": "Janssen-Cilag S.A.",
      "attrs": {
        "seat": "Antwerpseweg 15-17, 2340 Beerse"
      }
    },
    {
      "id": "e13",
      "kbo": null,
      "kind": "person",
      "name": "Sonja Willems",
      "attrs": {
        "address": "Kruisstraat 14, 3545 Halen",
        "birth_date": "1960-09-22",
        "birth_place": "Lier"
      }
    },
    {
      "id": "e14",
      "kbo": "0459.093.476",
      "kind": "company",
      "name": "Novartis Pharma S.A.",
      "attrs": {
        "seat": "Medialaan 40, bte 1, 1800 Vilvoorde"
      }
    },
    {
      "id": "e15",
      "kbo": "0464.435.901",
      "kind": "company",
      "name": "Sanofi Belgium S.A.",
      "attrs": {
        "seat": "Leonardo Da Vincilaan 19, 1831 Diegem"
      }
    },
    {
      "id": "e16",
      "kbo": "0403.047.965",
      "kind": "company",
      "name": "Merck S.A.",
      "attrs": {
        "seat": "Brusselsesteenweg 288, 3090 Overijse"
      }
    },
    {
      "id": "e17",
      "kbo": "0882.012.387",
      "kind": "company",
      "name": "Celgene SPRL",
      "attrs": {
        "seat": "Place du Luxembourg 1, 1420 Braine-L\u0027Alleud"
      }
    }
  ]
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0459.093.476",
    "name_full": "NOVARTIS PHARMA",
    "legal_form": "NV"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2020-05-27",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0459.093.476",
    "name_full": "NOVARTIS PHARMA",
    "legal_form": "SA"
  },
  "signature_regime": "joint_two",
  "special_mandates": [
    {
      "quote": "De vergadering verleent bijzondere volmacht aan Lannoy Joris, De Dier Stijn en elke andere advocaat of medewerker van het kantoor Quinz, allen woonstkeuze gedaan hebbende te 1800 Vilvoorde, Medialaan 28 B, allen individueel bevoegd, evenals aan hun bedienden, aangestelden en lasthebbers, met mogelijkheid tot indeplaatsstelling, teneinde de vervulling van de formaliteiten bij een ondernemingsloket met het oog op de inschrijving/aanpassing van de gegevens in de Kruispuntbank van Ondernemingen, en, desgevallend, bij de Administratie van de Belasting over de Toegevoegde Waarde, te verzekeren.",
      "holder_kbo": null,
      "holder_name": "Lannoy Joris",
      "scope_categories": [
        "KBO",
        "tax",
        "filing"
      ],
      "with_substitution": true
    },
    {
      "quote": "De vergadering verleent bijzondere volmacht aan Lannoy Joris, De Dier Stijn en elke andere advocaat of medewerker van het kantoor Quinz, allen woonstkeuze gedaan hebbende te 1800 Vilvoorde, Medialaan 28 B, allen individueel bevoegd, evenals aan hun bedienden, aangestelden en lasthebbers, met mogelijkheid tot indeplaatsstelling, teneinde de vervulling van de formaliteiten bij een ondernemingsloket met het oog op de inschrijving/aanpassing van de gegevens in de Kruispuntbank van Ondernemingen, en, desgevallend, bij de Administratie van de Belasting over de Toegevoegde Waarde, te verzekeren.",
      "holder_kbo": null,
      "holder_name": "De Dier Stijn",
      "scope_categories": [
        "KBO",
        "tax",
        "filing"
      ],
      "with_substitution": true
    },
    {
      "quote": "De vergadering verleent bijzondere volmacht aan Lannoy Joris, De Dier Stijn en elke andere advocaat of medewerker van het kantoor Quinz, allen woonstkeuze gedaan hebbende te 1800 Vilvoorde, Medialaan 28 B, allen individueel bevoegd, evenals aan hun bedienden, aangestelden en lasthebbers, met mogelijkheid tot indeplaatsstelling, teneinde de vervulling van de formaliteiten bij een ondernemingsloket met het oog op de inschrijving/aanpassing van de gegevens in de Kruispuntbank van Ondernemingen, en, desgevallend, bij de Administratie van de Belasting over de Toegevoegde Waarde, te verzekeren.",
      "holder_kbo": null,
      "holder_name": "kantoor Quinz",
      "scope_categories": [
        "KBO",
        "tax",
        "filing"
      ],
      "with_substitution": true
    }
  ],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Ann Cleenewerck",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0459093476",
        "name": "PwC Bedrijfsrevisoren bv",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2019-06-18",
      "evidence_quote": "PwC Bedrijfsrevisoren bv zal vanaf 18 juni 2019 vertegenwoordigd worden door Ann Cleenewerck, in de uitoefening van zijn mandaat van commissar\u00EDs, ter vervanging van Romain Seffer."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0459.093.476",
    "name_full": "NOVARTIS PHARMA",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Nicolas Thiriet",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2019-06-06",
      "evidence_quote": "De aandeelhouders benoemen de heer Nicolas Thiriet, met de Franse nationaliteit, met geboortedatum 25 april 1981, te dien eind met woonstkeuze op de zetel van de vennootschap, die aanvaardt, als bestuurder van de vennootschap en secretaris van de raad van bestuur en dit met onmiddellijke ingang en v"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0459.093.476",
    "name_full": "NOVARTIS PHARMA",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Romain Seffer",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0459093476",
        "name": "BCVBA PwC Bedrijfsrevisoren",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "De algemene vergadering benoemt de BCVBA PwC Bedrijfsrevisoren, met maatschappelijke zetel te 1932 Sint-Stevens-Woluwe, Woluwedal 18, als commissaris voor een termijn van drie jaar. Deze vennootschap heeft Dhr. Romain Seffer, bedrijfsrevisor, aangeduid als vertegenwoordiger die gemachtigd is haar te"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0459.093.476",
    "name_full": "NOVARTIS PHARMA",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Mark Never",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2017-11-01",
      "evidence_quote": "De Raad beslist om te voorzien in zijn vervanging door de co\u00F6ptatie tot bestuurder van de heer Mark Never, met woonstkeuze ten zetel van de vennootschap, Medialaan 40 te 1800 Vilvoorde. Het mandaat gaat in op 1 november 2017 en heeft een duurtijd van 6 jaar tot aan de Algemene Vergadering van 2023 d"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0459.093.476",
    "name_full": "NOVARTIS PHARMA",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Mark Never",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2017-11-01",
      "evidence_quote": "De Raad beslist om te voorzien in zijn vervanging door de co\u00F6ptatie tot bestuurder van de heer Mark Never, met woonstkeuze ten zetel van de vennootschap, Medialaan 40 te 1800 Vilvoorde. Het mandaat gaat in op 1 november 2017 en heeft een duurtijd van 6 jaar tot aan de Algemene Vergadering van 2023 d"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0459.093.476",
    "name_full": "NOVARTIS PHARMA",
    "legal_form": "NV"
  }
}

{
  "facts": [
    {
      "date": "2017-08-16",
      "type": "publication",
      "quote": "-16/08/2017-",
      "value": "16/08/2017",
      "object": null,
      "subject": null
    },
    {
      "date": "2017-08-04",
      "type": "filing",
      "quote": "D\u00E9pos\u00E9 / Re\u00E7u le 04 ADUT 2017",
      "value": "04/08/2017",
      "object": null,
      "subject": null
    },
    {
      "date": "2017-03-24",
      "type": "general_meeting",
      "quote": "ASSEMBLEE GENERALE DU 24 MARS 2017",
      "value": "24/03/2017",
      "object": null,
      "subject": null
    },
    {
      "date": "2017-03-24",
      "type": "officer_appointment",
      "quote": "Nomination de : 1. Merck S.A.",
      "value": {
        "role": "member of the Board of Directors",
        "start_date": "2017-03-24"
      },
      "object": null,
      "subject": "e1",
      "_value_raw": {
        "role": "member of the Board of Directors",
        "start_date": "24/03/2017"
      }
    },
    {
      "date": "2017-03-24",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: 1. Bristol-Myers Squibb Belgium S.A.",
      "value": {
        "role": "member of the Board of Directors",
        "start_date": "2017-03-24"
      },
      "object": null,
      "subject": "e2",
      "_value_raw": {
        "role": "member of the Board of Directors",
        "start_date": "24/03/2017"
      }
    },
    {
      "date": "2017-03-24",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: ... 2. GlaxoSmithKline Pharmaceuticals S.A.",
      "value": {
        "role": "member of the Board of Directors",
        "start_date": "2017-03-24"
      },
      "object": null,
      "subject": "e3",
      "_value_raw": {
        "role": "member of the Board of Directors",
        "start_date": "24/03/2017"
      }
    },
    {
      "date": "2017-03-24",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: ... 3. Janssen-Cilag S.A.",
      "value": {
        "role": "member of the Board of Directors",
        "start_date": "2017-03-24"
      },
      "object": null,
      "subject": "e4",
      "_value_raw": {
        "role": "member of the Board of Directors",
        "start_date": "24/03/2017"
      }
    },
    {
      "date": "2017-03-24",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: ... 4. Novartis Pharma S.A.",
      "value": {
        "role": "member of the Board of Directors",
        "start_date": "2017-03-24"
      },
      "object": null,
      "subject": "e5",
      "_value_raw": {
        "role": "member of the Board of Directors",
        "start_date": "24/03/2017"
      }
    },
    {
      "date": "2017-03-24",
      "type": "officer_reappointment",
      "quote": "Reconduction de la nomination de: ... 5. Sanofi Belgium S.A.",
      "value": {
        "role": "member of the Board of Directors",
        "start_date": "2017-03-24"
      },
      "object": null,
      "subject": "e6",
      "_value_raw": {
        "role": "member of the Board of Directors",
        "start_date": "24/03/2017"
      }
    },
    {
      "date": "2017-03-24",
      "type": "officer_appointment",
      "quote": "Catherine Rutten CEO charg\u00E9 de la gestion journali\u00E8re",
      "value": {
        "role": "charg\u00E9 de la gestion journali\u00E8re",
        "start_date": "2017-03-24"
      },
      "object": null,
      "subject": "e7",
      "_value_raw": {
        "role": "charg\u00E9 de la gestion journali\u00E8re",
        "start_date": "24/03/2017"
      }
    }
  ],
  "act_meta": {
    "outcome": "clean",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 1639,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0403.047.965",
      "kind": "company",
      "name": "Merck S.A.",
      "attrs": {
        "seat": "Brusselsesteenweg 288, 3090 Overijse"
      }
    },
    {
      "id": "e2",
      "kbo": "0403.075.184",
      "kind": "company",
      "name": "Bristol-Myers Squibb Belgium S.A.",
      "attrs": {
        "seat": "avenue de Finlande 4 Bte 48, 1420 Braine-L\u0027Alleud"
      }
    },
    {
      "id": "e3",
      "kbo": "0403.066.474",
      "kind": "company",
      "name": "GlaxoSmithKline Pharmaceuticals S.A.",
      "attrs": {
        "seat": "avenue Pascal 2-4-6, 1300 Wavre"
      }
    },
    {
      "id": "e4",
      "kbo": "0415.283.427",
      "kind": "company",
      "name": "Janssen-Cilag S.A.",
      "attrs": {
        "seat": "Antwerpseweg 15-17, 2340 Beerse"
      }
    },
    {
      "id": "e5",
      "kbo": "0459.093.476",
      "kind": "company",
      "name": "Novartis Pharma S.A.",
      "attrs": {
        "seat": "Medialaan 40, bte 1, 1800 Vilvoorde"
      }
    },
    {
      "id": "e6",
      "kbo": "0464.435.901",
      "kind": "company",
      "name": "Sanofi Belgium S.A.",
      "attrs": {
        "seat": "Leonardo Da Vincilaan 19, 1831 Diegem"
      }
    },
    {
      "id": "e7",
      "kbo": null,
      "kind": "person",
      "name": "Catherine Rutten",
      "attrs": {}
    }
  ]
}

{
  "facts": [
    {
      "date": "2017-08-16",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad.-16/08/2017-",
      "value": "16/08/2017",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2017-08-04",
      "type": "filing",
      "quote": "D\u00E9pos\u00E9 / Ra\u00E7u le 04 ADUT 2017",
      "value": "04/08/2017",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2017-03-24",
      "type": "general_meeting",
      "quote": "ALGEMENE VERGADERING VAN 24 MAART 2017",
      "value": "24/03/2017",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2017-03-24",
      "type": "officer_appointment",
      "quote": "Benoeming van: 1. Merck N.V.",
      "value": {
        "role": "lid van de Raad van Bestuur",
        "start_date": "2017-03-24"
      },
      "object": "e1",
      "subject": "e2",
      "_value_raw": {
        "role": "lid van de Raad van Bestuur",
        "start_date": "24/03/2017"
      }
    },
    {
      "date": "2017-03-24",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: 1. Bristol-Myers Squibb Belgium N.V.",
      "value": {
        "role": "lid van de Raad van Bestuur",
        "start_date": "2017-03-24"
      },
      "object": "e1",
      "subject": "e3",
      "_value_raw": {
        "role": "lid van de Raad van Bestuur",
        "start_date": "24/03/2017"
      }
    },
    {
      "date": "2017-03-24",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: ... 2. GlaxoSmithKline Pharmaceuticals N.V.",
      "value": {
        "role": "lid van de Raad van Bestuur",
        "start_date": "2017-03-24"
      },
      "object": "e1",
      "subject": "e4",
      "_value_raw": {
        "role": "lid van de Raad van Bestuur",
        "start_date": "24/03/2017"
      }
    },
    {
      "date": "2017-03-24",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: ... 3. Janssen-Cilag N.V.",
      "value": {
        "role": "lid van de Raad van Bestuur",
        "start_date": "2017-03-24"
      },
      "object": "e1",
      "subject": "e5",
      "_value_raw": {
        "role": "lid van de Raad van Bestuur",
        "start_date": "24/03/2017"
      }
    },
    {
      "date": "2017-03-24",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: ... 4. Novartis Pharma N.V.",
      "value": {
        "role": "lid van de Raad van Bestuur",
        "start_date": "2017-03-24"
      },
      "object": "e1",
      "subject": "e6",
      "_value_raw": {
        "role": "lid van de Raad van Bestuur",
        "start_date": "24/03/2017"
      }
    },
    {
      "date": "2017-03-24",
      "type": "officer_reappointment",
      "quote": "Herbenoeming van: ... 5. Sanofi Belgium N.V.",
      "value": {
        "role": "lid van de Raad van Bestuur",
        "start_date": "2017-03-24"
      },
      "object": "e1",
      "subject": "e7",
      "_value_raw": {
        "role": "lid van de Raad van Bestuur",
        "start_date": "24/03/2017"
      }
    },
    {
      "date": "2017-03-24",
      "type": "officer_appointment",
      "quote": "Catherine Rutten CEO belast met het dagelijks bestuur",
      "value": {
        "role": "CEO belast met het dagelijks bestuur",
        "start_date": "2017-03-24"
      },
      "object": "e1",
      "subject": "e8",
      "_value_raw": {
        "role": "CEO belast met het dagelijks bestuur",
        "start_date": "24/03/2017"
      }
    }
  ],
  "act_meta": {
    "outcome": "clean",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 1560,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0407.622.902",
      "kind": "company",
      "name": "Algemene Vereniging van de Geneesmiddelenindustrie",
      "attrs": {
        "seat": "Terhulpsesteenweg 166, 1170 BRUSSEL",
        "legal_form": "Vereniging zonder winstoogmerk",
        "short_name": "AVGI"
      }
    },
    {
      "id": "e2",
      "kbo": "0403.047.965",
      "kind": "company",
      "name": "Merck N.V.",
      "attrs": {
        "seat": "Brusselsesteenweg 288, 3090 Overijse"
      }
    },
    {
      "id": "e3",
      "kbo": "0403.075.184",
      "kind": "company",
      "name": "Bristol-Myers Squibb Belgium N.V.",
      "attrs": {
        "seat": "avenue de Finlande 4 Bte 48, 1420 Braine-L\u0027Alleud"
      }
    },
    {
      "id": "e4",
      "kbo": "0403.066.474",
      "kind": "company",
      "name": "GlaxoSmithKline Pharmaceuticals N.V.",
      "attrs": {
        "seat": "avenue Pascal 2-4-6, 1300 Wavre"
      }
    },
    {
      "id": "e5",
      "kbo": "0415.283.427",
      "kind": "company",
      "name": "Janssen-Cilag N.V.",
      "attrs": {
        "seat": "Antwerpseweg 15-17, 2340 Beerse"
      }
    },
    {
      "id": "e6",
      "kbo": "0459.093.476",
      "kind": "company",
      "name": "Novartis Pharma N.V.",
      "attrs": {
        "seat": "Medialaan 40 bus 1, 1800 Vilvoorde"
      }
    },
    {
      "id": "e7",
      "kbo": "0464.435.901",
      "kind": "company",
      "name": "Sanofi Belgium N.V.",
      "attrs": {
        "seat": "Leonardo Da Vincilaan 19, 1831 Diegem"
      }
    },
    {
      "id": "e8",
      "kbo": null,
      "kind": "person",
      "name": "Catherine Rutten",
      "attrs": {}
    }
  ]
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Philippe de Pougnadoresse",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2017-06-01",
      "evidence_quote": "De Vergadering stelt de heer Philippe de Pougnadoresse aan als bestuurder van de vennootschap, met woonstkeuze Medialaan 40 te 1800 Vilvoorde. Het mandaat gaat in op 1 juni 2017 en heeft een duurtijd van 6 jaar tot aan de Algemene Vergadering van 2023 die zal oordelen over de jaarrekening afgesloten"
    },
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Knut Mager",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "De Vergadering beslist om het mandaat van de heer Knut Mager te verlengen voor een nieuwe periode van 6 jaar tot aan de Algemene Vergadering van 2023 die zal oordelen over de jaarrekening afgesloten per 31 december 2022"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Dario Drago",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "De vergadering beslist om de co\u00F6ptatie van de heer Dario Drago als bestuurder van de venriootschap te bevestigen. Zijn mandaat loopt tot de Algemere Vergadering van 2023 die zal oordelen over de jaarrekening afgesloten er 31 december 2022."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0459.093.476",
    "name_full": "NOVARTIS PHARMA",
    "legal_form": "NV"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0459.093.476",
    "name_full": "NOVARTIS PHARMA",
    "legal_form": "NV"
  }
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0459.093.476",
    "name_full": "NOVARTIS PHARMA",
    "legal_form": "NV"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Dario Drago",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "De Raad van Bestuur co\u00F6pteert de heer Dario Drago als bestuurder van de vennootschap, met woonstkeuze ten zetel van de vennootschap, Medialaan 40 te 1800 Vilvoorde."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0459.093.476",
    "name_full": "NOVARTIS PHARMA",
    "legal_form": "NV"
  }
}